Summary:
In order to determine the influence of HA-1 minor histocompatibility antigen mismatch on BMT outcome, we analyzed a pool of 94 thalassemic transplanted patients all selected for the presence of HLA-A*0201 allele. The HA-1 typing was performed using SSP analysis. All the patients received bone marrow from HLA-identical MLC nonresponsive siblings. As graft-versus-host-disease (GVHD) prophylaxis, all patients received cyclosporin and short methotrexate. Grades II–IV GVHD occurred in five (33.3%) of the 15 patients with recipient HA-1 disparity compared with 14 (17.7%) of the 79 patients without HA-1 disparity. Despite the higher incidence of acute graft-versus-host-disease (aGVHD) in the group of patients with HA-1 incompatibility, these data were not statistically significant. However, it was interesting to observe that no GVHD developed in any of the 15 cases in which the recipient was HA-1 negative and the donor HA-1 positive.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Sullivan KM . Graft-versus-host disease. In: Forman SJ, Blume KG, Thomas DE (eds). Bone Marrow Transplantation. Blackwell: Boston, 1994, pp 339–362.
Lucarelli G, Galimberti M, Polchi P et al. Marrow transplantation in patients with thalassemia responsive to iron chelation therapy. N Engl J Med 1993; 329: 840–844.
Gaziev D, Polchi P, Galimberti M et al. Graft-versus-host-disease after bone marrow transplantation for thalassemia: an analysis of incidence and risk factors. Transplantation 1997; 63: 854–860.
Goulmy E, Schipper R, Pool J et al. Mismatches of minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft-versus-host disease after bone marrow Transplantation. N Engl J Med 1996; 334: 281–285.
Mutis T, Gillespie G, Schrama E et al. Tetrameric HLA class I-minor histocompatibility antigen peptide complexes demonstrate minor istocompatibility antigen-specific cytotoxic T lymphocytes in patients with graft-versus-host disease. Nat Med 1999; 5: 839–842.
den Haan JMM, Meadows LM, Wang W et al. The minor histocompatibility antigen HA-1: a diallelic gene with a single amino acid polymorphism. Science 1998; 279: 1054–1057.
Lin MT, Gooley T, Hansen JA et al. Absence of statistically significant correlation between disparity for the minor histocompatibility antigen HA-1 and outcome after allogeneic hematopoietic cell transplantation. Blood 2001; 98: 317–3173.
Thomas ED, Storb R, Clift RA et al. Bone marrow transplantation. N Engl J Med 1975; 292: 832–843.
Wilke M, Pool J, den Haan JMH, Goulmy E . Genomic identification of the minor histocompatibility antigen HA-1 locus by allele specific PCR. Tissue Antigens 1998; 52: 312–317.
Kurz B, Steiert I, Heuchert G et al. New high resolution typing strategy for HLA-A locus alleles based on dye terminator sequencing of haplotypic group-specific PCR-amplicons of exon 2 and exon 3. Tissue Antigens 1999; 53: 81–96.
Tseng LH, Lin MT, Martin PJ et al. Definition of the gene encoding the minor histocompatibility antigen HA-1 and typing for HA-1 from genomic DNA. Tissue Antigens 1998; 52: 305–311.
Van Els CA, D’Amaro J, Pool J et al. Immunogenetics of human minor histocompatibility antigens: their polymorphism and immunodominance. Immunogenetics 1992; 35: 161–655.
Tseng LH, Lin MT, Hansen JA et al. Correlation between disparity for the minor histocompatibility antigen HA-1 and the development of acute graft versus host disease after allogeneic marrow transplantation. Blood 1999; 94: 2911–2914.
Gallardo D, Arostegui JI, Balas A et al. Disparity for the minor histocompatibility antigen HA-1 is associated with an increased risk of acute graft versus host disease (GVHD) but it does not affect chronic GVHD incidence, disease-free-survival or overall survival after allogeneic human leucocyte antigen-identical sibling donor transplantation. Br J Haematol 2001; 114: 931–936.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Nesci, S., Buffi, O., Iliescu, A. et al. Recipient mHag-HA1 disparity and aGVHD in thalassemic-transplanted patients. Bone Marrow Transplant 31, 575–578 (2003). https://doi.org/10.1038/sj.bmt.1703880
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1703880
Keywords
This article is cited by
-
Polymorphisms in the base excision repair pathway and graft-versus-host disease
Leukemia (2010)
-
Distribution of the minor histocompatibility antigens in Korean population and disparities in unrelated hematopoietic SCT
Bone Marrow Transplantation (2007)